ARBUTUS BIOPHARMA CORP's ticker is ABUS and the CUSIP is 03879J100. A total of 49 filers reported holding ARBUTUS BIOPHARMA CORP in Q3 2016. The put-call ratio across all filers is 3.68 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2017 | $3,625,000 | -10.6% | 1,115,263 | -32.6% | 0.36% | -15.6% |
| Q4 2016 | $4,055,000 | -55.0% | 1,655,162 | -36.8% | 0.43% | -39.9% |
| Q3 2016 | $9,006,000 | -1.2% | 2,618,000 | 0.0% | 0.71% | +6.9% |
| Q2 2016 | $9,111,000 | -15.7% | 2,618,000 | 0.0% | 0.67% | -6.0% |
| Q1 2016 | $10,812,000 | -7.2% | 2,618,000 | 0.0% | 0.71% | -5.3% |
| Q4 2015 | $11,650,000 | -26.9% | 2,618,000 | 0.0% | 0.75% | -31.9% |
| Q3 2015 | $15,944,000 | – | 2,618,000 | – | 1.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Whitefort Capital Management, LP | 11,895,477 | $24,147,818 | 12.66% |
| Two Seas Capital LP | 8,280,818 | $16,810,061 | 3.38% |
| FourWorld Capital Management LLC | 1,341,907 | $2,724,071 | 0.51% |
| Tejara Capital Ltd | 180,077 | $365,556 | 0.21% |
| Woodline Partners LP | 4,719,903 | $9,581,403 | 0.11% |
| Hudson Bay Capital Management LP | 8,299,808 | $16,848,610 | 0.07% |
| Kepos Capital LP | 155,691 | $316 | 0.06% |
| Virtus ETF Advisers LLC | 40,040 | $81,281 | 0.05% |
| Centiva Capital, LP | 1,071,705 | $2,175,561 | 0.05% |
| Kades & Cheifetz LLC | 20,000 | $40,600 | 0.03% |